Loading…
ADVIL COLD & SINUS EXTRA STRENGTH LIQUI-GELS is a brand name for Ibuprofen, supplied as a capsule. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Advil Cold And Sinus, Advil Cold And Sinus Daytime (Ibuprofen and Pseudoephedrine Hydrochloride Tablets), Advil Cold & Sinus Liqui-Gels and Advil Cold & Sinus Extra Strength Liqui-Gels (Ibuprofen (free acid and potassium salt) and Pseudoephedrine Hydrochloride Capsules) are indicated for: • the temporary relief of…
Verbatim from this product's HC label. Tap a section to expand.
2 Recommended Dose and Dosage Adjustment 11/2024 TABLE OF CONTENTS Sections or subsections that are not applicable at the time of authorization are not listed. RECENT MAJOR LABEL CHANGES ..........................................................................................
2 TABLE OF CONTENTS ............................................................................................................ 2 PART I: HEALTH PROFESSIONAL INFORMATION ....................................................................
5 1 INDICATIONS ............................................................................................................. 1 Pediatrics..................................................................................................................
2 Geriatrics .................................................................................................................. 5 2 CONTRAINDICATIONS ................................................................................................
5 3 SERIOUS WARNINGS AND PRECAUTIONS BOX ........................................................... 7 4 DOSAGE AND ADMINISTRATION................................................................................ 1 Dosing Considerations .............................................................................................
2 Recommended Dose and Dosage Adjustment ........................................................ 4 Administration ......................................................................................................... 5 Missed Dose .............................................................................................................
8 5 OVERDOSAGE............................................................................................................ 9
1 Adverse Reaction Overview Serious adverse reactions occur uncommonly with Advil Cold & Sinus products. The most common reactions include heartburn, constipation, nausea, bloating, nervousness or sleeplessness. 2 Clinical Trial Adverse Reactions Clinical trials are conducted under very specific conditions.
The adverse reaction rates observed in the clinical trials; therefore, may not reflect the rates observed in practice and should not be compared to the rates in the clinical trials of another drug. Adverse reaction information from clinical trials may be useful in identifying and approximating rates of adverse drug reactions in real-world use.
Safety Studies of Ibuprofen and Pseudoephedrine Combination In patients with upper respiratory infections treated with either ibuprofen 200 mg plus pseudoephedrine 30 mg (n = 294), acetaminophen 500 mg (n = 296), or placebo (n = 146), the frequency of adverse events (mostly gastrointestinal and CNS symptoms) was similar among the three treatment groups.
In a placebo-controlled, double-blind clinical study of 58 subjects with rhinovirus infection, pseudoephedrine given alone or with ibuprofen was well-tolerated. Symptoms associated with sympathetic stimulation tended to be more frequent in subjects who were treated with pseudoephedrine (60 mg, either alone or with 200 mg ibuprofen) than in those who received placebo.
The three treatment groups were similar in mean pulse rate and mean blood pressure. 9 years). In one of the studies, 104 children took the medication for up to 7 days to treat symptoms of upper respiratory infection. 8. The other two studies were single-dose pharmacokinetic studies.
” The symptom resolved after study medication was discontinued. In combined data from the three studies, the most frequently reported adverse events were somnolence (in seven children), vomiting (in three children), and otitis media (in three children) (Table 1).
2 Recommended Dose and Dosage Adjustment 11/2024 TABLE OF CONTENTS Sections or subsections that are not applicable at the time of authorization are not listed. RECENT MAJOR LABEL CHANGES ..........................................................................................
2 TABLE OF CONTENTS ............................................................................................................ 2 PART I: HEALTH PROFESSIONAL INFORMATION ....................................................................
5 1 INDICATIONS ............................................................................................................. 1 Pediatrics..................................................................................................................
2 Geriatrics .................................................................................................................. 5 2 CONTRAINDICATIONS ................................................................................................
5 3 SERIOUS WARNINGS AND PRECAUTIONS BOX ........................................................... 7 4 DOSAGE AND ADMINISTRATION................................................................................ 1 Dosing Considerations .............................................................................................
2 Recommended Dose and Dosage Adjustment ........................................................ 4 Administration ......................................................................................................... 5 Missed Dose .............................................................................................................
8 5 OVERDOSAGE............................................................................................................ 9 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING .............................. 11 7 WARNINGS AND PRECAUTIONS ...............................................................................
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Ibuprofen in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
Only two adverse events were considered severe: somnolence in one child, which lasted for about 1 hour and was considered remotely related to study medication, and ear pain, which resolved within 2 days without treatment and was considered unrelated to study medication.
All other adverse events were considered mild or moderate in intensity. ADVIL COLD AND SINUS / DAYTIME Ibuprofen and Pseudoephedrine Hydrochloride Tablets ADVIL COLD & SINUS LIQUI-GELS / ADVIL COLD & SINUS EXTRA STRENGTH LIQUI-GELS Ibuprofen (free acid and potassium salt) and Pseudoephedrine Hydrochloride Capsules CHILDREN’S ADVIL COLD Ibuprofen and Pseudoephedrine Hydrochloride Suspension Page 23 of 78 Table 1 Adverse Events in Clinical Studies of Children’s Advil Cold Body System COSTART Term Number (%) of Subjects Reporting Event (N = 156) Body as a whole Asthenia 2 (1%) Fever 2 (1%) Back pain 1 (<1%) Common cold 1 (<1%) Headache 1 (<1%) Pain 1 (<1%) Chills 1 (<1%) Digestive Vomiting 3 (2%) Abdominal pain 2 (1%) Nausea 2 (1%) Diarrhoea 1 (<1%) Dyspepsia 1 (<1%) Haemic and lymphatic Lymphadenopathy 1 (<1%) Lymphocytosis 1 (<1%) Nervous Somnolence 7 (4%) Tremor 2 (1%) Hyperkinesia 1 (<1%) Nervousness 1 (<1%) Respiratory Rhinitis 2 (1%) Skin and appendages Pruritus 1 (<1%) Rash 2 (1%) Special senses Otitis media 3 (2%) Conjunctivitis 1 (<1%) Ear disorder 1 (<1%) Ear pain 1 (<1%) Two large-scale safety studies of ibuprofen examined the potential risk in children of several rare events that are related to the pharmacological action of NSAIDs: GI bleeding, acute renal failure, and anaphylaxis.
5 Post-Market Adverse Reactions Safety Studies of Ibuprofen - children The Children’s Analgesic Medicine Project (CAMP) was a multicenter, all-comers, open-label, nonrandomized, prospective study comparing the safety of ibuprofen suspension with acetaminophen suspension in children with fever and/or pain.
A total of 424 paediatricians enrolled children at 69 US ADVIL COLD AND SINUS / DAYTIME Ibuprofen and Pseudoephedrine Hydrochloride Tablets ADVIL COLD & SINUS LIQUI-GELS / ADVIL COLD & SINUS EXTRA STRENGTH LIQUI-GELS Ibuprofen (free acid and potassium salt) and Pseudoephedrine Hydrochloride Capsules CHILDREN’S ADVIL COLD Ibuprofen and Pseudoephedrine Hydrochloride Suspension Page 24 of 78 clinics; 14,281 were <2 years of age and 15,863 were 2 to <12 years of age.
Among children <2 years of age, fever, vomiting, diarrhoea, rhinitis, rash, and otitis media were the only adverse events with frequency >1% in either treatment group (ibuprofen or acetaminophen). Among children 2 years of age, the only adverse events with frequency >1% in either treatment group were rhinitis, pharyngitis, and otitis media.
Adverse events were generally mild to moderate for both treatments within the two age groups. There were no serious adverse events, (no anaphylaxis, Reye syndrome, renal failure, or GI bleeding/perforation). 6% vs. 9% vs. 7%). The difference may have been due to the preference of physicians to treat the sicker children with ibuprofen.
Overall, ibuprofen exhibited an adverse event profile similar to that of acetaminophen. The Boston Fever Study was a randomized, double-blind study that assessed the risk of rare but serious adverse events after the use of ibuprofen suspension in febrile children between 6 months and 12 years of age.
The study evaluated a total of 83,915 children enrolled by 1735 paediatricians, family physicians, and general practitioners in the United States. Children were randomly assigned to receive ibuprofen […]
1 Special Populations ................................................................................................ 1 Pregnant Women ............................................................................................. 2 Breastfeeding ...................................................................................................
3 Pediatrics.......................................................................................................... 4 Geriatrics (> 65 years of age) ........................................................................... 21 8 ADVERSE REACTIONS...............................................................................................
1 Adverse Reaction Overview ................................................................................... 2 Clinical Trial Adverse Reactions ............................................................................. 1 Clinical Trial Adverse Reactions – Pediatrics....................................................
5 Post-Market Adverse Reactions............................................................................. 23 9 DRUG INTERACTIONS .............................................................................................. 1 Serious Drug Interactions ......................................................................................
2 Drug Interactions Overview ................................................................................... 3 Drug-Behavioural Interactions ............................................................................... 4 Drug-Drug Interactions ..........................................................................................
5 Drug-Food Interactions .......................................................................................... 6 Drug-Herb Interactions .......................................................................................... 7 Drug-Laboratory Test Interactions.........................................................................
34 10 CLINICAL PHARMACOLOGY ...................................................................................... 1 Mechanism of Action ....................................................................................... 2 Pharmacodynamics ..........................................................................................
3 Pharmacokinetics ............................................................................................. 37 11 STORAGE, STABILITY AND DISPOSAL ........................................................................ 40 12 SPECIAL HANDLING INSTRUCTIONS..........................................................................
40 PART II: SCIENTIFIC INFORMATION ..................................................................................... 41 13 PHARMACEUTICAL INFORMATION .......................................................................... 41 14 CLINICAL TRIALS ......................................................................................................
1 Clinical Trials by Indication .............................................................................. 2 Comparative Bioavailability Studies ................................................................ 45 ADVIL COLD AND SINUS / DAYTIME Ibuprofen and Pseudoephedrine Hydrochloride Tablets ADVIL COLD & SINUS LIQUI-GELS / ADVIL […]